[SCHEDULE 13G] SpringWorks Therapeutics, Inc. SEC Filing
Hudson Bay Capital Management LP and Sander Gerber report beneficial ownership of 3,936,857 shares of SpringWorks Therapeutics, representing 5.22% of the outstanding common stock. The reported position includes 3,529,200 shares issuable upon exercise of call options. The filings show no sole voting or dispositive power and shared voting and dispositive power of 3,936,857 shares, indicating the securities are held in the name of the fund managed by the Investment Manager.
The Schedule 13G filing includes a certification that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer. The ownership percentage is calculated using an outstanding share base of 75,348,995 shares as disclosed in the company proxy.
Hudson Bay Capital Management LP e Sander Gerber dichiarano la titolarit脿 beneficiaria di 3.936.857 azioni di SpringWorks Therapeutics, pari al 5,22% del capitale sociale in circolazione. La posizione segnalata include 3.529.200 azioni sottostanti a opzioni call esercitabili. Nei documenti risulta nessun potere decisionale o di voto esclusivo e un potere di voto e di disposizione condiviso su 3.936.857 azioni, il che indica che i titoli sono intestati al fondo gestito dall'Investment Manager.
Il modulo Schedule 13G riporta la certificazione che i titoli sono stati acquisiti e sono detenuti nell'ordinario svolgimento dell'attivit脿 e non allo scopo di modificare o influenzare il controllo dell'emittente. La percentuale di partecipazione 猫 calcolata su una base di 75.348.995 azioni in circolazione, come indicato nella proxy della societ脿.
Hudson Bay Capital Management LP y Sander Gerber informan la propiedad beneficiaria de 3.936.857 acciones de SpringWorks Therapeutics, lo que representa el 5,22% del capital social en circulaci贸n. La posici贸n reportada incluye 3.529.200 acciones exigibles por el ejercicio de opciones call. Las presentaciones muestran ausencia de poder exclusivo de voto o disposici贸n y poder compartido de voto y disposici贸n sobre 3.936.857 acciones, lo que indica que los valores est谩n registrados a nombre del fondo gestionado por el Investment Manager.
El formulario Schedule 13G incluye una certificaci贸n de que los valores fueron adquiridos y se mantienen en el curso ordinario del negocio y no con la finalidad de cambiar o influir en el control del emisor. El porcentaje de participaci贸n se calcula usando una base de 75.348.995 acciones en circulaci贸n, seg煤n se revela en el proxy de la compa帽铆a.
Hudson Bay Capital Management LP鞕� Sander Gerber電� SpringWorks Therapeutics鞚� 3,936,857欤�鞐� 雽�頃� 鞁れ鞝� 靻岇湢甓岇潉 氤搓碃頄堨溂氅�, 鞚措姅 氚滍枆 氤错喌欤� 欷� 5.22%鞐� 頃措嫻頃╇媹雼�. 氤搓碃霅� 韽靺橃棎電� 頄夓偓 臧�電ロ暅 旖滌樀靺橃溂搿� 氚滍枆霅� 3,529,200欤�臧� 韽暔霅橃柎 鞛堨姷雼堧嫟. 鞝滌稖 靹滊鞐愲姅 雼弲 鞚橁舶甓� 霕愲姅 觳橂秳甓岇潃 鞐嗞碃 3,936,857欤检棎 雽�頃� 瓿惦彊 鞚橁舶甓� 氚� 觳橂秳甓岆 鞛堨潓鞙茧 旮办灛霅橃柎 鞛堨柎 頃措嫻 歃濌秾鞚� 韴瀽 毵る媹鞝�臧� 鞖挫毄頃橂姅 韼�霌� 氇呾潣搿� 氤挫湢霅橁碃 鞛堨潓鞚� 雮橅儉雰呺媹雼�.
Schedule 13G 鞝滌稖靹滌棎電� 鞚� 歃濌秾霌れ澊 鞓侅梾 瓿检爼鞐愳劀 旆摑路氤挫湢霅� 瓴冹澊氅� 氚滍枆靷潣 歆�氚瓣秾鞚� 氤�瓴巾晿瓯半倶 鞓來枼霠レ潉 頄夓偓頃橂牑電� 氇╈爜鞚� 鞎勲嫎鞚� 鞚胳頃橂姅 雮挫毄鞚� 韽暔霅橃柎 鞛堨姷雼堧嫟. 靻岇湢 牍勳湪鞚� 須岇偓鞚� 鞙勳瀯鞛�(proxy)鞐� 旮办灛霅� 氚滍枆欤检嫕靾� 75,348,995欤�毳� 旮办鞙茧 瓿勳偘霅橃棃鞀惦媹雼�.
Hudson Bay Capital Management LP et Sander Gerber d茅clarent la propri茅t茅 b茅n茅ficiaire de 3 936 857 actions de SpringWorks Therapeutics, soit 5,22 % des actions ordinaires en circulation. La position d茅clar茅e comprend 3 529 200 actions susceptibles d'锚tre 茅mises en cas d'exercice d'options d'achat (call). Les documents indiquent l'absence de pouvoir de vote ou de disposition exclusif et un pouvoir de vote et de disposition partag茅 sur 3 936 857 actions, ce qui sugg猫re que les titres sont d茅tenus au nom du fonds g茅r茅 par l'Investment Manager.
Le d茅p么t Schedule 13G contient une certification indiquant que les titres ont 茅t茅 acquis et sont d茅tenus dans le cadre normal des activit茅s et non dans le but de modifier ou d'influencer le contr么le de l'茅metteur. Le pourcentage de d茅tention est calcul茅 sur une base de 75 348 995 actions en circulation, comme indiqu茅 dans la procuration (proxy) de la soci茅t茅.
Hudson Bay Capital Management LP und Sander Gerber melden eine wirtschaftliche Beteiligung an 3.936.857 Aktien von SpringWorks Therapeutics, was 5,22% des ausstehenden Stammkapitals entspricht. Die gemeldete Position beinhaltet 3.529.200 Aktien, die bei Aus眉bung von Call-Optionen ausgegeben werden. In den Unterlagen wird kein alleiniges Stimm- oder Verf眉gungsrecht und ein gemeinsames Stimm- und Verf眉gungsrecht 眉ber 3.936.857 Aktien angegeben, was darauf hinweist, dass die Wertpapiere auf den Namen des vom Investment Manager verwalteten Fonds gehalten werden.
Die Schedule-13G-Einreichung enth盲lt eine Erkl盲rung, dass die Wertpapiere im gew枚hnlichen Gesch盲ftsverlauf erworben und gehalten wurden und nicht mit dem Zweck, die Kontrolle des Emittenten zu 盲ndern oder zu beeinflussen. Die Beteiligungsquote wurde auf Basis von 75.348.995 ausstehenden Aktien berechnet, wie in der Aktion盲rsvollmacht (Proxy) des Unternehmens angegeben.
- Beneficial ownership disclosed: 3,936,857 shares (5.22% of class)
- Options included: 3,529,200 shares issuable upon exercise of call options
- Institutional holding: Securities held in the name of Hudson Bay Master Fund Ltd. via the Investment Manager
- No sole voting or dispositive power: Sole voting and dispositive power reported as 0
- Concentration: Position represents a material 5.22% stake in the company
Insights
TL;DR Hudson Bay reports a passive 5.22% stake (3.94M shares, incl. 3.53M option shares) in SpringWorks.
The filing shows an institutional position held in the name of Hudson Bay Master Fund Ltd., with Hudson Bay Capital Management LP as investment manager. Reported holdings total 3,936,857 shares, of which 3,529,200 are exercisable call options, and the percentage is based on 75,348,995 shares outstanding per the company proxy. The cover information indicates shared voting and dispositive power and no sole voting or dispositive power. The Item 10 certification states the position is held in the ordinary course and not to influence control.
TL;DR The Schedule 13G disclosure signals a non-control, institutional stake of 5.22% reported jointly by Hudson Bay and Sander Gerber.
The statement identifies the Investment Manager as holding the securities on behalf of Hudson Bay Master Fund Ltd., and Mr. Gerber disclaims beneficial ownership while serving as managing member of the general partner. The filing reports shared voting/dispositive power for the reported shares and contains a certification that the holdings were not acquired to change or influence issuer control, consistent with a passive 13G disclosure.
Hudson Bay Capital Management LP e Sander Gerber dichiarano la titolarit脿 beneficiaria di 3.936.857 azioni di SpringWorks Therapeutics, pari al 5,22% del capitale sociale in circolazione. La posizione segnalata include 3.529.200 azioni sottostanti a opzioni call esercitabili. Nei documenti risulta nessun potere decisionale o di voto esclusivo e un potere di voto e di disposizione condiviso su 3.936.857 azioni, il che indica che i titoli sono intestati al fondo gestito dall'Investment Manager.
Il modulo Schedule 13G riporta la certificazione che i titoli sono stati acquisiti e sono detenuti nell'ordinario svolgimento dell'attivit脿 e non allo scopo di modificare o influenzare il controllo dell'emittente. La percentuale di partecipazione 猫 calcolata su una base di 75.348.995 azioni in circolazione, come indicato nella proxy della societ脿.
Hudson Bay Capital Management LP y Sander Gerber informan la propiedad beneficiaria de 3.936.857 acciones de SpringWorks Therapeutics, lo que representa el 5,22% del capital social en circulaci贸n. La posici贸n reportada incluye 3.529.200 acciones exigibles por el ejercicio de opciones call. Las presentaciones muestran ausencia de poder exclusivo de voto o disposici贸n y poder compartido de voto y disposici贸n sobre 3.936.857 acciones, lo que indica que los valores est谩n registrados a nombre del fondo gestionado por el Investment Manager.
El formulario Schedule 13G incluye una certificaci贸n de que los valores fueron adquiridos y se mantienen en el curso ordinario del negocio y no con la finalidad de cambiar o influir en el control del emisor. El porcentaje de participaci贸n se calcula usando una base de 75.348.995 acciones en circulaci贸n, seg煤n se revela en el proxy de la compa帽铆a.
Hudson Bay Capital Management LP鞕� Sander Gerber電� SpringWorks Therapeutics鞚� 3,936,857欤�鞐� 雽�頃� 鞁れ鞝� 靻岇湢甓岇潉 氤搓碃頄堨溂氅�, 鞚措姅 氚滍枆 氤错喌欤� 欷� 5.22%鞐� 頃措嫻頃╇媹雼�. 氤搓碃霅� 韽靺橃棎電� 頄夓偓 臧�電ロ暅 旖滌樀靺橃溂搿� 氚滍枆霅� 3,529,200欤�臧� 韽暔霅橃柎 鞛堨姷雼堧嫟. 鞝滌稖 靹滊鞐愲姅 雼弲 鞚橁舶甓� 霕愲姅 觳橂秳甓岇潃 鞐嗞碃 3,936,857欤检棎 雽�頃� 瓿惦彊 鞚橁舶甓� 氚� 觳橂秳甓岆 鞛堨潓鞙茧 旮办灛霅橃柎 鞛堨柎 頃措嫻 歃濌秾鞚� 韴瀽 毵る媹鞝�臧� 鞖挫毄頃橂姅 韼�霌� 氇呾潣搿� 氤挫湢霅橁碃 鞛堨潓鞚� 雮橅儉雰呺媹雼�.
Schedule 13G 鞝滌稖靹滌棎電� 鞚� 歃濌秾霌れ澊 鞓侅梾 瓿检爼鞐愳劀 旆摑路氤挫湢霅� 瓴冹澊氅� 氚滍枆靷潣 歆�氚瓣秾鞚� 氤�瓴巾晿瓯半倶 鞓來枼霠レ潉 頄夓偓頃橂牑電� 氇╈爜鞚� 鞎勲嫎鞚� 鞚胳頃橂姅 雮挫毄鞚� 韽暔霅橃柎 鞛堨姷雼堧嫟. 靻岇湢 牍勳湪鞚� 須岇偓鞚� 鞙勳瀯鞛�(proxy)鞐� 旮办灛霅� 氚滍枆欤检嫕靾� 75,348,995欤�毳� 旮办鞙茧 瓿勳偘霅橃棃鞀惦媹雼�.
Hudson Bay Capital Management LP et Sander Gerber d茅clarent la propri茅t茅 b茅n茅ficiaire de 3 936 857 actions de SpringWorks Therapeutics, soit 5,22 % des actions ordinaires en circulation. La position d茅clar茅e comprend 3 529 200 actions susceptibles d'锚tre 茅mises en cas d'exercice d'options d'achat (call). Les documents indiquent l'absence de pouvoir de vote ou de disposition exclusif et un pouvoir de vote et de disposition partag茅 sur 3 936 857 actions, ce qui sugg猫re que les titres sont d茅tenus au nom du fonds g茅r茅 par l'Investment Manager.
Le d茅p么t Schedule 13G contient une certification indiquant que les titres ont 茅t茅 acquis et sont d茅tenus dans le cadre normal des activit茅s et non dans le but de modifier ou d'influencer le contr么le de l'茅metteur. Le pourcentage de d茅tention est calcul茅 sur une base de 75 348 995 actions en circulation, comme indiqu茅 dans la procuration (proxy) de la soci茅t茅.
Hudson Bay Capital Management LP und Sander Gerber melden eine wirtschaftliche Beteiligung an 3.936.857 Aktien von SpringWorks Therapeutics, was 5,22% des ausstehenden Stammkapitals entspricht. Die gemeldete Position beinhaltet 3.529.200 Aktien, die bei Aus眉bung von Call-Optionen ausgegeben werden. In den Unterlagen wird kein alleiniges Stimm- oder Verf眉gungsrecht und ein gemeinsames Stimm- und Verf眉gungsrecht 眉ber 3.936.857 Aktien angegeben, was darauf hinweist, dass die Wertpapiere auf den Namen des vom Investment Manager verwalteten Fonds gehalten werden.
Die Schedule-13G-Einreichung enth盲lt eine Erkl盲rung, dass die Wertpapiere im gew枚hnlichen Gesch盲ftsverlauf erworben und gehalten wurden und nicht mit dem Zweck, die Kontrolle des Emittenten zu 盲ndern oder zu beeinflussen. Die Beteiligungsquote wurde auf Basis von 75.348.995 ausstehenden Aktien berechnet, wie in der Aktion盲rsvollmacht (Proxy) des Unternehmens angegeben.
FAQ
How many SpringWorks (SWTX) shares does Hudson Bay report owning?
What percentage of SWTX does the reported position represent?
Does the reported ownership include option shares?
Does Hudson Bay have sole voting control over these SWTX shares?
On what share count is the 5.22% based?
